Preethi Jeyaraman

Dr. Preethi Jeyaraman Specialist Clinical Hematology


Years of Experience : 8

Nationality : India

Languages Known : English, Tamil, Hindi, Telugu

Book Appointment

Biography

Dr. Preethi Jeyaraman is an experienced Clinical Hematologist at Burjeel Medical City. She brings with her vast experience from her training and practice in India. Dr. Preethi completed her MBBS in India in 2010. Later, she pursued her MD in Internal Medicine in India in 2014. She also holds a DM in Clinical Hematology from India, completed in 2017. With over 8 years of experience in the field, Dr. Preethi has played various key roles in hematology. She brings vast experience in patient counseling in OPD, sick inpatient care, various hematology procedures, and maintaining hospital records. Dr. Preethi holds numerous publications under her name. She has played key roles such as Junior Resident, Clinical Observer, and Assistant Professor in Medical Oncology. Prior to joining the Burjeel family, she served as a Consultant in Hematology and Bone Marrow Transplant at a renowned hospital in India. 

Awards & Achievements

  • National Hematoncology Quiz Winner 2012
  • Distinction in Biochemistry, Pharmacology, Forensic medicine, Ophthalmology and General Surgery

Research & Publications

  • Unusual case of cord compression - A pressing issue for neurosurgeons. Kamalkant Sahu, Pruthvi Sanamandra, Preethi Jeyaraman, Ganesh kumar, Gaurav Prakash, Narender Kumar, Pankaj Malhotra. World neurosurgery 92 (2016): 565-567.
  • Bullae and Blisters: A rare case of Bendamustine skin toxicity, Kamalkant Sahu, GU Sawatkar, Preethi Jeyaraman, Gaurav Prakash, Subhash Varma; Indian Journal of Hematology and Blood Transfusion, suppl. Supplement; New Delhi32(Jun 2016): 368-369.
  • Utility of clinical and complete Rockall score in Indian patients with upper gastrointestinal bleeding, Vishal Sharma, Preethi Jeyaraman, Surinder S Rana, Rajesh Gupta, Samir Malhotra, Ashish Bhalla, Deepak K Bhasin, http://dx.doi.org/10.7869/tg.373
  • Synchronous hairy cell leukemia and chronic lymphocytic leukemia: a case report with a brief review of literature. Rastogi P, Jeyaraman P, Sachdeva MU, Malhotra P, Ahluwalia J. Blood Res. 2018 Jun;53(2):160-163.
  • Highlights of Abstracts on Hematopoietic Stem Cell Transplant in Annual Conference of ISHBT 2018. Jeyaraman P. & Naithani R. Indian J Hematol Blood Transfus (2019) 35: 12. https://doi.org/10.1007/s12288-018-01067-5
  • Naithani R, Jeyaraman P, Dayal N. Hematogone Hyperplasia Masquerading as Acute Lymphoblastic Leukemia with Concurrent Hypercupremia [published online ahead of print, 2019 Oct 4]. J Pediatr Hematol Oncol. 2019;10.1097/MPH.0000000000001606. doi: 10.1097/MPH.0000000000001606
  • Jeyaraman P, Borah P, Rajput P, Dayal N, Pathak S, Naithani R. Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia [published online ahead of print, 2020 Jul 2]. Blood Cells Mol Dis. 2020;102464. doi: 10.1016/j.bcmd.2020.102464
  • Jeyaraman P, Naithani R. Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia. J Pediatr Hematol Oncol. 2020;42(1):e64-e65. doi: 10.1097/MPH.0000000000001624
  • Jeyaraman P, Borah P, Dayal N, Pathak S, Naithani R. Adequate Engraftment with Lower Hematopoietic Stem Cell Dose. Clin Lymphoma Myeloma Leuk. 2020;20(4):260-263. doi: 10.1016/j.clml.2019.12.018
  • Jeyaraman P, Bhasin A, Dayal N, Pathak S, Naithani R. Daratumumab in dialysis-dependent multiple myeloma. Blood Res. 2020;55(1):65-67. doi: 10.5045/br.2020.55.1.65
  • Bansal A, Jeyaraman P, Gupta SK, Dayal N, Naithani R. Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell PUBLICATIONS transplantation. Am J Blood Res. 2020 Dec 15;10(6):339-344. eCollection 2020.
  • Sarkar J, Jeyaraman P, Naithani R. Hypercalcemia Related Pancreatitis in a Patient with Multiple Myeloma. Indian J Hematol Blood Transfus. 2020;36(1):200-201. doi: 10.1007/s12288-019-01166-x
  • Jeyaraman P, Borah P, Singh A, et al. Thrombotic microangiopathy after carfilzomib in a very young myeloma patient. Blood Cells Mol Dis. 2020;81:102400. doi: 10.1016/j.bcmd.2019.102400
  • Naithani R, Jeyaraman P, Saikia B, Dayal N, Pathak S. Paroxysmal Cold Hemoglobinuria in a 4-year-old Child. Indian Pediatr. 2019;56(10):879-880.
  • Jha SK, Borah P, Jeyaraman P, et al. All That Lights-Up is not Lymphoma. Indian J Hematol Blood Transfus. 2020;36(1):213-214. doi: 10.1007/s12288-019-01185-8
  • Borah P, Jeyaraman P, Sethi S, Naithani R, Anand R. Primary Cardiac Lymphoma. Indian J Hematol Blood Transfus. 2020;36(2):419-421. doi: 10.1007/s12288-019- 01221-7
  • Borah P, Mirgh S, Sharma SK, Bansal S, Dixit A, Dolai TK, Lunkad S, Gupta N, Singh G, Jain A, Bansal D, Choudhary D, Khandelwal V, Doval D, Kumar M, Bhargava R, Chakrabarti A, Kalashetty M, Rauthan A, Kazi B, Mandal PK, Jeyaraman P, Naithani R; AIIMS Hematology Alumni Group. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. Blood Cells Mol Dis. 2021 Mar;87:102525. doi: 10.1016/j.bcmd.2020.102525. Epub 2020 Dec 8.
  • Jeyaraman P, Borah P, Rajput P, Dayal N, Pathak S, Naithani R. Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia. Blood Cells Mol Dis. 2021 May;88:102464. doi: 10.1016/j.bcmd.2020.102464. Epub 2020 Jul 2.
  • Jeyaraman P, Agrawal N, Bhargava R, Bansal D, Ahmed R, Bhurani D, Bansal S, Rastogi N, Borah P, Naithani R; Delhi Hematology Group. Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies. Transfus Apher Sci. 2021 Jun;60(3):103075. doi: 10.1016/j.transci.2021.103075. Epub 2021 Feb 3.
  • Agrawal N, Singh R, Sharma SK, Naithani R, Bhargava R, Choudhary D, Jeyaraman P, Bansal S, Doval D, Khandelwal V, Bansal N, Ahmed R, Bhurani D. Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: Multicenter Retrospective Analysis. Indian J Hematol Blood Transfus. 2021 Jul 16:1-6. doi: 10.1007/s12288-021-01472-3. Online ahead of print.

Education & Training

  • MBBS, The Tamil Nadu MGR Medical University, Chennai, India - 2010 
  • MD, Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh - 2014
  • DM, Clinical Hematology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh - 2017

Expertise

  • Managing benign hematology patients including anemia, thrombocytopenia, bleeding diathesis and thrombophilia.
  • Managing malignant hematology patients including leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms.
  • Autologous and Allogeneic stem cell transplant.

Membership

  • Indian society of hematology and blood transfusion
  • Indian society of blood and marrow transplant

Blogs